ALDH1A3 in CSCs
- PMID: 28476022
- PMCID: PMC5472733
- DOI: 10.18632/aging.101236
ALDH1A3 in CSCs
Keywords: ALDH1A3; cancer stem cell; glioma stem cell; retinoic acid; tissue transglutaminase.
Similar articles
-
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.Oncotarget. 2017 Apr 4;8(14):22325-22343. doi: 10.18632/oncotarget.16479. Oncotarget. 2017. PMID: 28423611 Free PMC article.
-
ALDH1A3, a metabolic target for cancer diagnosis and therapy.Int J Cancer. 2016 Sep 1;139(5):965-75. doi: 10.1002/ijc.30091. Epub 2016 Apr 4. Int J Cancer. 2016. PMID: 26991532 Review.
-
ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.PLoS One. 2015 Nov 17;10(11):e0142856. doi: 10.1371/journal.pone.0142856. eCollection 2015. PLoS One. 2015. PMID: 26575197 Free PMC article.
-
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.Cell Death Differ. 2020 Jan;27(1):363-378. doi: 10.1038/s41418-019-0362-1. Epub 2019 Jun 13. Cell Death Differ. 2020. PMID: 31197235 Free PMC article.
-
Tissue transglutaminase in the pathogenesis of heart failure.Cell Death Differ. 2018 Mar;25(3):453-456. doi: 10.1038/s41418-017-0028-9. Epub 2017 Dec 13. Cell Death Differ. 2018. PMID: 29238072 Free PMC article. Review. No abstract available.
Cited by
-
MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer.Biosci Rep. 2020 Apr 30;40(4):BSR20200390. doi: 10.1042/BSR20200390. Biosci Rep. 2020. Retraction in: Biosci Rep. 2024 Sep 25;44(9):BSR-2020-0390_RET. doi: 10.1042/BSR-2020-0390_RET. PMID: 32270866 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources